Opioid use during pregnancy impacts the health and well‐being of two generations: the
pregnant person and the child. The factors that increase risk for opioid use in the adult, as …

A significant number of advances have been made in the last 5 years with respect to the
identification, diagnosis, assessment, and management of infants with prenatal opioid …

OBJECTIVE To Address challenges in clinical care, quality improvement, research, and
public policy for prenatally opioid-exposed neonates by standardizing the clinical definition …

Importance Pharmacologic agents are often used to treat newborns with prenatal opioid
exposure (POE) despite known adverse effects on neurodevelopment. Alternative …

Early child neurodevelopment, including psychopathology, is influenced by a myriad of
factors and interactions. These factors are both intrinsic to the caregiver–child dyad such as …

Maternal opioid use poses a significant health concern not just to the expectant mother but
also to the fetus. Notably, increasing numbers of children born suffering from neonatal opioid …

Background Newborns with prenatal opioid exposure (POE) are commonly diagnosed with
neonatal abstinence/opioid-withdrawal syndromes due to characteristic symptoms and overt …

Opioids have a rapid transplacental passage (ie, less than 60 min); furthermore, symptoms
characterize the maternal and fetal withdrawal syndrome. Opioid withdrawal significantly …

Background: An infant's cognitive development is highly dependent on early interactions
with its primary caregiver, often its mother. Feeding, a frequent and early exchange between …

Substance use disorders (SUD) among caregiving adults has inexorable linkage to the
health and well-being of millions of children in the US This piece provides an overview of …